Nowa Zelandia - angielski - Medsafe (Medicines Safety Authority)

merck sharp & dohme (new zealand) limited - posaconazole 18 mg/ml;   - concentrate for injection - 300mg/16.7ml - active: posaconazole 18 mg/ml   excipient: disodium edetate hydrochloric acid sodium hydroxide sulfobutyl betadex sodium water for injection - noxafil (posaconazole) concentrated injection is indicated for use in the treatment of the following invasive fungal infections in adults: - invasive aspergillosis in patients intolerant of, or with disease that is refractory to, alternative therapy. - fusariosis, zygomycosis, coccidioidomycosis, chromoblastomycosis, and mycetoma in patients intolerant of, or with disease that is refractory to, alternative therapy. noxafil is also indicated for the: - prophylaxis of invasive fungal infections among adults, who are at high risk of developing these infections, such as patients with prolonged neutropenia or haematopoietic stem cell transplant (hsct) recipients.

Stany Zjednoczone - angielski - NLM (National Library of Medicine)

vitality works, inc. - chamomilla (chamomile) 4x, colocynthsis (bitter cucumber) 4x, pulsatilla (wind flower) 4x, aethusa cynapium (fools parsley) 6x, dioscorea villosa (wild yam) 6x, magnesia phosphorica (magensium phophate) 6x - for the temporary relief of colic symptoms, including stomach pain, vomiting, gas, cramping and irritability. for the temporary relief of colic symptoms, including stomach pain, vomiting, gas, cramping and irritability